hemp

(3)
Legend
Chad Collins
Founder · Executive · Author

Chad Collins

Chad Collins is the co-founder, chairman and CEO of Corganics, a Dallas-based clinical cannabinoid company that sells pharmaceutical-grade, broad-spectrum CBD exclusively through healthcare professionals. A 20-year veteran of biopharma, payor systems and medical devices - including stints as a VP at Galderma and CEO of Boston Select Asset Group - he co-founded Corganics in January 2020 with Reggie Gatewood to drag CBD out of what he calls the retail 'Wild West' and into the clinic. He is also the author of 'Run to the Fire,' the true story of his father, a doubly amputated Vietnam veteran, with a foreword by NFL Hall of Famer Roger Staubach.

chad-collins · corganicsRead →
Company
The Arcview Group
Vc · Fintech · Health

The Arcview Group

The Arcview Group is a vertically integrated cannabis and hemp company founded in 2010 by activists-turned-entrepreneurs Troy Dayton and Steve DeAngelo. Built around the Arcview Investor Network - one of the first and largest groups of accredited investors backing legal cannabis - it pairs capital and brokerage with the industry's most-cited market research, business consulting, events, and social-equity initiatives. Headquartered in San Francisco, Arcview has helped channel hundreds of millions of dollars into more than 200 cannabis companies and turned a once-illicit market into investable territory.

cannabis · cannabis-investmentRead →
Legend
Jeffrey Finkle
Investor · Executive · Founder

Jeffrey Finkle

Jeffrey Finkle is the CEO of The Arcview Group, the vertically integrated firm that has bankrolled and brokered the legal cannabis, hemp, and psychedelics industries for over a decade. A software entrepreneur turned venture investor since 1999, he co-founded the $115M Odeon Capital Partners during the dot-com peak, spent years as a fixture of New York's angel scene, and now runs Arcview's events, capital, ventures, consulting, and research arms with social equity written into the charter.

cannabis-investing · venture-capitalRead →